Evidence map›Paper›PMID 35731216›Full record

ArticleGenetics2022

Interactions of Caenorhabditis elegans β-tubulins with the microtubule inhibitor and anthelmintic drug albendazole.

Linda M Pallotto, Clayton M Dilks, Ye-Jean Park, Ryan B Smit, Brian T Lu, Chandrasekhar Gopalakrishnan, John S Gilleard, Erik C Andersen, Paul E Mains

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Linda M PallottoDepartment of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB T2N 4N1, Canada.
Clayton M DilksMolecular Biosciences, Northwestern University, Evanston, IL 60208, USA.ORCID 0000-0002-4622-8460
Ye-Jean ParkDepartment of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB T2N 4N1, Canada.
Ryan B SmitDepartment of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB T2N 4N1, Canada.
Brian T LuDepartment of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB T2N 4N1, Canada.
Chandrasekhar GopalakrishnanDepartment of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB T2N 4N1, Canada.
John S GilleardDepartment of Comparative Biology and Experimental Medicine, Host-Parasite Interactions (HPI) Program, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.ORCID 0000-0002-6787-4699
Erik C AndersenMolecular Biosciences, Northwestern University, Evanston, IL 60208, USA.ORCID 0000-0003-0229-9651
Paul E MainsDepartment of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB T2N 4N1, Canada.ORCID 0000-0002-4099-4287
University of Calgary · CANorthwestern University · US

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
Discovery of Novel Benzimidazole Resistance MechanismsR01AI153088 · NIAID · NORTHWESTERN UNIVERSITY · PI Erik Christian Andersen, James Solomon Fraser · 2020 to 2026
$4.3M
NIAID NIH HHS R01 AI153088NIH HHS P40 OD010440
6 · The paper itself

Abstract

Parasitic nematodes are major human and agricultural pests, and benzimidazoles are amongst the most important broad-spectrum anthelmintic drug class used for their control. Benzimidazole resistance is now widespread in many species of parasitic nematodes in livestock globally and an emerging concern for the sustainable control of human soil-transmitted helminths. β-tubulin is the major benzimidazole target, although other genes may influence resistance. Among the 6 Caenorhabditis elegans β-tubulin genes, loss of ben-1 causes resistance without other apparent defects. Here, we explored the genetics of C. elegans β-tubulin genes in relation to the response to the benzimidazole derivative albendazole. The most highly expressed β-tubulin isotypes, encoded by tbb-1 and tbb-2, were known to be redundant with each other for viability, and their products are predicted not to bind benzimidazoles. We found that tbb-2 mutants, and to a lesser extent tbb-1 mutants, were hypersensitive to albendazole. The double mutant tbb-2 ben-1 is uncoordinated and short, resembling the wild type exposed to albendazole, but the tbb-1 ben-1 double mutant did not show the same phenotypes. These results suggest that tbb-2 is a modifier of albendazole sensitivity. To better understand how BEN-1 mutates to cause benzimidazole resistance, we isolated mutants resistant to albendazole and found that 15 of 16 mutations occurred in the ben-1 coding region. Mutations ranged from likely nulls to hypomorphs, and several corresponded to residues that cause resistance in other organisms. Null alleles of ben-1 are albendazole-resistant and BEN-1 shows high sequence identity with tubulins from other organisms, suggesting that many amino acid changes could cause resistance. However, our results suggest that missense mutations conferring resistance are not evenly distributed across all possible conserved sites. Independent of their roles in benzimidazole resistance, tbb-1 and tbb-2 may have specialized functions as null mutants of tbb-1 or tbb-2 were cold or heat sensitive, respectively.

Indexed as

AnthelminticsTubulinAlbendazoleAnimalsBenzimidazolesCaenorhabditis elegansDrug ResistanceHumansMicrotubulesTubulin ModulatorsAlbendazoleAnthelminticsBenzimidazolesTubulinTubulin ModulatorsalbendazolebenzimidazoleCaenorhabditis elegansdrug resistancemicrotubulestubulin

Identifiers

PMID35731216
PMCPMC9339285
OpenAlexW4283325036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.